Galectin-3 contributes to neonatal hypoxic-ischemic brain injury.
about
Pathophysiology and neuroprotection of global and focal perinatal brain injury: lessons from animal modelsBarrier mechanisms in neonatal strokeStructure of a tetrameric galectin fromCinachyrellasp. (ball sponge)Neuroprotection by the histone deacetylase inhibitor trichostatin A in a model of lipopolysaccharide-sensitised neonatal hypoxic-ischaemic brain injury.Absence of mutations in four genes encoding for congenital cataract and expressed in the human brain in Tunisian families with cataract and mental retardationTherapeutic benefits of delayed lithium administration in the neonatal rat after cerebral hypoxia-ischemia.The role of Galectin-3 in α-synuclein-induced microglial activation.Cord blood neutrophils display a galectin-3 responsive phenotype accentuated by vaginal delivery.Regulation of toll-like receptor 1 and -2 in neonatal mice brains after hypoxia-ischemiaNovel neuroinflammatory targets in the chronically injured spinal cordBaby STEPS: a giant leap for cell therapy in neonatal brain injuryDelayed inflammatory mRNA and protein expression after spinal cord injury.Lithium-mediated long-term neuroprotection in neonatal rat hypoxia-ischemia is associated with antiinflammatory effects and enhanced proliferation and survival of neural stem/progenitor cells.Angiogenesis dysregulation in term asphyxiated newborns treated with hypothermia.Hypoxia Up-Regulates Galectin-3 in Mammary Tumor Progression and Metastasis.Role of galectin-3 in acetaminophen-induced hepatotoxicity and inflammatory mediator production.Modeling Ischemia in the Immature Brain: How Translational Are Animal Models?Galectin-3 released in response to traumatic brain injury acts as an alarmin orchestrating brain immune response and promoting neurodegeneration.Neuroprotective Effect of 3-(Naphthalen-2-Yl(Propoxy)Methyl)Azetidine Hydrochloride on Brain Ischaemia/Reperfusion Injury.Deletion of galectin-3 exacerbates microglial activation and accelerates disease progression and demise in a SOD1(G93A) mouse model of amyotrophic lateral sclerosisRole of galectin-3 in classical and alternative macrophage activation in the liver following acetaminophen intoxication.Microglia/macrophage-derived inflammatory mediators galectin-3 and quinolinic acid are elevated in cerebrospinal fluid from newborn infants after birth asphyxiaCharacterization of phenotype markers and neuronotoxic potential of polarised primary microglia in vitroGalectin-3 causes enteric neuronal loss in mice after left sided permanent middle cerebral artery occlusion, a model of stroke.Prognostic value of plasma galectin-3 levels after aneurysmal subarachnoid hemorrhage.Protective effect of 3-(naphthalen-2-yl(propoxy)methyl)azetidine hydrochloride on hypoxia-induced toxicity by suppressing microglial activation in BV-2 cells.Potential involvement of glycogen synthase kinase (GSK)-3β in a rat model of multiple sclerosis: evidenced by lithium treatmentPathophysiological role of inflammatory molecules in paediatric ischaemic brain injury.mRNA Transcriptomics of Galectins Unveils Heterogeneous Organization in Mouse and Human Brain.Towards molecular mechanisms regulating the expression of galectins in cancer cells under microenvironmental stress conditions.Galectin-3 Negatively Regulates Hippocampus-Dependent Memory Formation through Inhibition of Integrin Signaling and Galectin-3 PhosphorylationGalectin-3 disruption impaired tumoral angiogenesis by reducing VEGF secretion from TGFβ1-induced macrophages.Tissue- and cell-specific localization of galectins, β-galactose-binding animal lectins, and their potential functions in health and disease.Galectin-3 enhances angiogenic and migratory potential of microglial cells via modulation of integrin linked kinase signaling.Decreased vulnerability of hippocampal neurons after neonatal hypoxia-ischemia in bis-deficient mice.Live imaging of the innate immune response in neonates reveals differential TLR2 dependent activation patterns in sterile inflammation and infection.Temporal Characterization of Microglia/Macrophage Phenotypes in a Mouse Model of Neonatal Hypoxic-Ischemic Brain Injury.Activated Microglia Desialylate and Phagocytose Cells via Neuraminidase, Galectin-3, and Mer Tyrosine KinaseMyelin loss and oligodendrocyte pathology in white matter tracts following traumatic brain injury in the rat.Galectin-3: an emerging biomarker in stroke and cerebrovascular diseases.
P2860
Q27000069-19FF639B-5C12-4F5F-9F28-39E647554231Q27025854-8BA8AA38-0525-4FE0-8325-B0E925671BFFQ27671912-0620FF96-773B-4CA7-999B-EEA570EB9822Q30524207-91B354C6-B341-48D5-B973-7C1FB9CDAE50Q34079601-6E79BB9E-2BAA-4529-8EE8-844C3C7178ACQ34166139-E77E5356-C694-403D-A1A8-267849363398Q34537231-4C2F0E81-0141-478C-9FEC-1CCF9F0692D6Q34960351-DD37C1DB-6BCF-4E9E-8AB8-58279D7C0169Q35003734-A34B6FBF-AC0B-438D-8ECF-78CB0156B3CAQ35006471-5816EF06-5CF4-4DF0-8465-4B0A4288FA04Q35051518-B70A12CD-28FF-4DEB-BB9C-151A8B14758BQ35416093-CE68AEC3-19AA-4FB7-A54B-A89FED371A30Q35524174-447C29D1-F912-4271-992E-E58A8BF8E18EQ35634208-A622F4CF-B621-4BC0-AD24-975BB9AF9420Q35723085-754B0776-E577-47FB-9BCB-0102EF82024AQ35969291-CF741F23-460F-448B-B9E9-D2491A3977A9Q36109006-B67A6476-687C-4C00-9ABE-6D60B6E066B2Q36262236-8E66A4BF-07CD-492E-A129-BB8694FF130EQ36293417-988304D3-4245-4D0E-BC3B-1F0BCFE3A856Q36373508-7DF44481-A931-4F52-825F-CC7E5DB4C688Q36456913-C372F826-3E04-4436-80FF-F1223254CEC4Q36937939-87363FCF-470F-4547-AAA5-768D99E238C7Q36959383-A5E14D5D-02C3-4232-88DF-6185B72F020DQ37244310-2F5DFC78-06F3-4B55-806F-6B62ED2ED5F2Q37339791-5E284EFD-2DC3-4627-830A-298AEF1A36A1Q37694131-D315CF61-0336-43F2-BE2E-B5CB3F08727CQ37746692-F7988659-7BAF-4128-A4EE-9228A44EE8FAQ37976090-B19BCBE7-B18C-481F-907C-46CDF004D5FAQ38438717-453C0F25-BC39-4AD9-8138-38034D3D41BCQ38561302-31BBDFBA-C83B-4BD1-94AB-11AA02DF8801Q38661342-B8BEA75E-264F-45A3-B8F4-D766D5070460Q38758852-05228329-CDF5-48DB-A93C-2C85401C0B0AQ38945365-0FC154DF-85D5-45C6-8310-7B1E94ACC8A5Q39224810-6ED96E4E-036E-4B53-AA9E-2C0E8ABEFEF5Q39294087-36A405A8-C8A9-4801-80C9-11EADE8E0CA9Q40185660-8212334B-E304-45DF-8EA8-38A6F31E93C6Q41854447-0686A5D9-2AEF-415F-9B53-6B067FE147EAQ42223040-50AB4997-F9F6-4FFA-BDAA-9841C48C5DBBQ44942078-64D3C796-F0D8-48D8-83DA-EA96C0CE990DQ47733264-88FCECC5-2A48-418D-A0D3-E02CA1CB8DE6
P2860
Galectin-3 contributes to neonatal hypoxic-ischemic brain injury.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Galectin-3 contributes to neonatal hypoxic-ischemic brain injury.
@en
Galectin-3 contributes to neonatal hypoxic-ischemic brain injury.
@nl
type
label
Galectin-3 contributes to neonatal hypoxic-ischemic brain injury.
@en
Galectin-3 contributes to neonatal hypoxic-ischemic brain injury.
@nl
prefLabel
Galectin-3 contributes to neonatal hypoxic-ischemic brain injury.
@en
Galectin-3 contributes to neonatal hypoxic-ischemic brain injury.
@nl
P2093
P1476
Galectin-3 contributes to neonatal hypoxic-ischemic brain injury.
@en
P2093
Anna Karlsson
Christina Doverhag
Françoise Poirier
Karin Sävman
Maj Hedtjärn
P356
10.1016/J.NBD.2009.12.024
P577
2010-01-04T00:00:00Z